市場調査レポート
商品コード
1187262
DTC (Direct-to-Consume) 遺伝学的検査の世界市場 (2023年~2032年):市場規模 (検査タイプ・技術・流通チャネル別)・地域的展望・用途の潜在性・競合市場シェア・予測Direct-to-Consumer Genetic Testing Market Size By Test Type, By Technology, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 - 2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
DTC (Direct-to-Consume) 遺伝学的検査の世界市場 (2023年~2032年):市場規模 (検査タイプ・技術・流通チャネル別)・地域的展望・用途の潜在性・競合市場シェア・予測 |
出版日: 2023年01月13日
発行: Global Market Insights Inc.
ページ情報: 英文 190 Pages
納期: 2~3営業日
|
DTC (Direct-to-Consume) 遺伝学的検査の市場規模は、主に新興国を中心とした可処分所得の増加により、2023年から2032年にかけて大幅な成長を遂げると予想されています。
また、遺伝性疾患や希少遺伝性疾患の検出・診断に関する意識の高まりも市場需要を後押しする見通しです。
検査別で見ると、ニュートリゲノミクス検査の部門は2032年にかけて13.5%超のCAGRで成長すると予測されています。また、技術別では、希少な遺伝性疾患の症例が増加していることから、全ゲノムシーケンシングの部門が市場をリードすると考えられています。さらに、地域別では、北米が2032年末には49億米ドル超を示すと予測されています。
当レポートでは、世界のDTC (Direct-to-Consume) 遺伝学的検査の市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制・償還環境、技術情勢、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。
Direct-to-Consumer (DTC) Genetic Testing Market is anticipated to gain substantial growth between 2023 and 2032, primarily due to the rising disposable incomes, especially in emerging countries. For instance, a report claims that between 2019 and 2030, the annual disposable income, ranging from USD 45,000 to USD 100,000 will increase by more than 5.5% per year.
Besides, the increasing awareness about the detection and diagnosis of hereditary and rare genetic diseases among the general populace across the globe will also fuel the market demand. Furthermore, experts in the field believe that genetic testing will become a regular part of clinical care, which will also favor the market in the foreseeable future.
In addition, the key providers in the DTC genetic testing industry are also seeking to strengthen their foothold in the market by investing in R&D projects and engaging in meaningful mergers, acquisitions, and joint ventures. To cite an instance, in December 2022, it was reported that researchers at the BC Cancer Research Institute have advanced genetic testing procedures, which allows better identification of those genes that can eventually lead to cancer.
Overall, the DTC genetic testing market has been segmented in terms of test, technology, distribution channel, and region.
Based on the test, the nutrigenomic testing segment is anticipated to grow significantly over the next ten years, and by 2032 this segment should grow at over 13.5% CAGR. Nutrigenomic testing boasts of advantages such as identifying locations of metabolic weakness, understanding the safety profile and toxicity of micro and macronutrients, and preventing diet diseases.
On the basis of technology, the market growth is likely to be characterized by the whole genome sequencing segment. The segmental growth can be credited to the increasing cases of rare genetic disorders. Besides, the technology is also being widely accepted as it provides a base-by-base view and a high resolution of the genome, apart from accessing large data and identifying potential causes, which will further fuel the market demand through 2032.
In terms of the distribution channel, the online platform segment is anticipated to grow at a robust rate through 2023-2032, owing to the increasing number of online websites which facilitate direct-to-consumer genetic testing.
In the regional context, the North America DTC genetic testing market is anticipated to be valued at more than USD 4.9 billion by 2032 end. The regional market growth can be attributed to the increasing usage of DTC genetic tests in the region since they have reduced the mortality rates of patients.